Breaking News Instant updates and real-time market news.

LHO

LaSalle Hotel

$29.42

0.13 (0.44%)

10:51
10/06/17
10/06
10:51
10/06/17
10:51

LaSalle Hotel: Damage from Irma at Key West resorts 'not significant'

LaSalle Hotel Properties provided a second Hurricane Irma impact update regarding its resorts in Key West, Florida. After both resorts closed on Wednesday, September 6, 2017 to comply with all mandatory evacuations of the island ahead of Hurricane Irma, the Southernmost Beach Resort has partially re-opened and The Marker Waterfront Resort remains closed. The company has not identified any structural damage at either of its resorts. While the company is still assessing the condition of both properties, it currently believes that the damage is not significant and is primarily related to water intrusion. The company expects both resorts will resume full operations by the end of October 2017. The company is evaluating the financial impact to both resorts and will provide another update on its third quarter earnings call on October 20, 2017. As previously stated, the company maintains property, flood, fire, and business interruption insurance at its two resorts in Key West. For the combined properties, insurance is subject to deductibles of approximately $5M in total.

  • 20

    Oct

  • 08

    Nov

  • 30

    Nov

LHO LaSalle Hotel
$29.42

0.13 (0.44%)

04/12/17
BOSC
04/12/17
INITIATION
Target $35
BOSC
LaSalle Hotel initiated with an Outperform at Boenning & Scattergood
Boenning & Scattergood analyst Floris van Dijkum initiated LaSalle Hotel with an Outperform and a $35 price target saying its largest market exposure is in Washington DC, which should serve well in 2017 as it traditionally does well in political administration transition years.
08/02/17
GSCO
08/02/17
DOWNGRADE
Target $24
GSCO
Sell
LaSalle Hotel downgraded to Sell from Neutral at Goldman Sachs
Goldman analyst Stephen Grambling downgraded LaSalle Hotel to Sell with a $24 price target saying it has among the greatest fundamental risk from a continued slowdown in corporate spending due to exposure to urban markets and shares trade at a premium.
08/24/17
BOSC
08/24/17
DOWNGRADE
BOSC
Neutral
LaSalle Hotel downgraded to Neutral from Outperform at Boenning & Scattergood
Boenning & Scattergood analyst Floris van Dijkum downgraded LaSalle Hotel to Neutral citing recent share outperformance and potential declining comparable EBITDA that could pressure future NAV.
08/24/17
08/24/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Teva (TEVA) downgraded to Underperform from Neutral at Credit Suisse by analyst Vamil Divan, saying that while Teva has dramatically reduced 2017 guidance, the core challenges they are facing should not fade anytime soon. The analyst pointed out that pricing pressure and increased competition in the U.S. generics business will remain, the appointment of a full-time CEO is still pending and the threat of generic competition to Copaxone 40mg still looms. 2. Lowe's (LOW) downgraded to Market Perform from Outperform at BMO Capital by analyst Wayne Hood based on the company's results and guidance which he said were "disappointing." The analyst expects the company's profitability to remain "challenged" going forward. 3. Dick's Sporting (DKS) downgraded to Market Perform from Outperform at Cowen, saying it had overestimated the company's ability to achieve its prior guidance and maintain its profitability. Cowen pointed to a number of headwinds for Dick's, including increasing digital competition and the negative side of industry cyclical trends. 4. J.M. Smucker (SJM) downgraded to Neutral from Overweight at JPMorgan. 5. LaSalle Hotel (LHO) downgraded to Neutral from Outperform at Boenning & Scattergood by analyst Floris van Dijkum citing recent share outperformance and potential declining comparable EBITDA that could pressure future NAV. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

INBK

First Internet Bancorp

$31.05

-0.55 (-1.74%)

07:07
09/24/18
09/24
07:07
09/24/18
07:07
Conference/Events
First Internet Bancorp management to meet with Craig Hallum »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 15

    Nov

MDWD

MediWound

$6.40

(0.00%)

07:07
09/24/18
09/24
07:07
09/24/18
07:07
Hot Stocks
MediWound awarded additional BARDA contract valued up to $43M »

MediWound announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Oct

SRPT

Sarepta

$147.81

-5.105 (-3.34%)

07:07
09/24/18
09/24
07:07
09/24/18
07:07
Hot Stocks
Sarepta announces FDA lift of clinical hold on DMD micro-dystrophin gene program »

Sarepta announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GFN

General Finance Corp

$14.20

(0.00%)

07:06
09/24/18
09/24
07:06
09/24/18
07:06
Hot Stocks
General Finance Corp unit to acquire assets of Instant Storage »

General Finance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUM

Humana

$337.80

0.09 (0.03%)

07:06
09/24/18
09/24
07:06
09/24/18
07:06
Conference/Events
Humana management to meet with Morgan Stanley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

LOOP

Loop Industries

$9.49

0.84 (9.71%)

07:06
09/24/18
09/24
07:06
09/24/18
07:06
Hot Stocks
Loop Industries, Indorama ventures JV to manufacter sustainable polyester resin »

Indorama Ventures Public…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MD

Mednax

$45.60

-1.91 (-4.02%)

07:05
09/24/18
09/24
07:05
09/24/18
07:05
Upgrade
Mednax rating change  »

Mednax upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBP

First BanCorp

$9.17

0.14 (1.55%)

07:05
09/24/18
09/24
07:05
09/24/18
07:05
Conference/Events
First BanCorp management to meet with Sandler O'Neill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 28

    Sep

  • 25

    Oct

07:05
09/24/18
09/24
07:05
09/24/18
07:05
General news
Oil Action: Front-month WTI crude prices are up 1.6% »

Oil Action: Front-month…

KRYS

Krystal Biotech

$16.88

-0.37 (-2.14%)

07:04
09/24/18
09/24
07:04
09/24/18
07:04
Initiation
Krystal Biotech initiated  »

Krystal Biotech initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 01

    Oct

  • 03

    Oct

ACRS

Aclaris Therapeutics

$15.18

-0.24 (-1.56%)

07:04
09/24/18
09/24
07:04
09/24/18
07:04
Hot Stocks
Aclaris Therapeutics initiates Phase 3 wart program for A-101 »

Aclaris Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 27

    Nov

T

AT&T

$33.88

0.44 (1.32%)

07:03
09/24/18
09/24
07:03
09/24/18
07:03
Recommendations
AT&T analyst commentary  »

Deutsche Bank adds…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 06

    Nov

  • 12

    Nov

P

Pandora

$9.08

-0.31 (-3.30%)

07:03
09/24/18
09/24
07:03
09/24/18
07:03
Earnings
Pandora backs Q3 revenue view $390M-$405M, consensus $401.45M »

Pandora reiterated its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

07:02
09/24/18
09/24
07:02
09/24/18
07:02
Earnings
Sirius XM backs FY18 guidance for revenue of over $5.7B, consensus $5.76B »

SiriusXM reiterated its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

EPZM

Epizyme

$10.30

-0.1 (-0.96%)

07:02
09/24/18
09/24
07:02
09/24/18
07:02
Conference/Events
Epizyme to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 02

    Oct

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

, P

Pandora

$9.08

-0.31 (-3.30%)

07:02
09/24/18
09/24
07:02
09/24/18
07:02
Hot Stocks
Sirius XM to acquire Pandora in all-stock transaction valuing Pandora at $3.5B »

Sirius XM Holdings (SIRI)…

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

P

Pandora

$9.08

-0.31 (-3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

MYL

Mylan

$38.98

0.25 (0.65%)

07:01
09/24/18
09/24
07:01
09/24/18
07:01
Hot Stocks
Mylan, Atomo Diagnostics announce strategic partnership »

Mylan and Atomo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

BLK

BlackRock

$488.00

0.94 (0.19%)

, PAM

Pampa Energia

$37.79

1.09 (2.97%)

07:01
09/24/18
09/24
07:01
09/24/18
07:01
Periodicals
BlackRock, other funds circle troubled Argentine companies, Bloomberg says »

BlackRock (BLK), Carval…

BLK

BlackRock

$488.00

0.94 (0.19%)

PAM

Pampa Energia

$37.79

1.09 (2.97%)

YPF

YPF

$17.04

-0.1 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 17

    Oct

MD

Mednax

$45.60

-1.91 (-4.02%)

07:00
09/24/18
09/24
07:00
09/24/18
07:00
Upgrade
Mednax rating change  »

Mednax upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

, P

Pandora

$9.08

-0.31 (-3.30%)

07:00
09/24/18
09/24
07:00
09/24/18
07:00
Hot Stocks
Breaking Hot Stocks news story on Sirius XM, Pandora »

Sirius XM to acquire…

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

P

Pandora

$9.08

-0.31 (-3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

BIO

Bio-Rad

$298.45

-2.74 (-0.91%)

07:00
09/24/18
09/24
07:00
09/24/18
07:00
Recommendations
Bio-Rad analyst commentary  »

Jefferies boosts Bio-Rad…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVP

Avon Products

$2.44

0.035 (1.46%)

, NUS

Nu Skin

$84.46

0.6 (0.72%)

06:58
09/24/18
09/24
06:58
09/24/18
06:58
Upgrade
Avon Products, Nu Skin, Herbalife Nutrition rating change  »

Avon Products upgraded to…

AVP

Avon Products

$2.44

0.035 (1.46%)

NUS

Nu Skin

$84.46

0.6 (0.72%)

HLF

Herbalife Nutrition

$54.98

-0.05 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

IDXG

Interpace Diagnostics

$1.53

-0.11 (-6.71%)

06:57
09/24/18
09/24
06:57
09/24/18
06:57
Hot Stocks
Interpace Diagnostics approved to lauch newest thyroid product, ThyGeNEXT »

Interpace Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JKS

JinkoSolar

$12.35

-0.13 (-1.04%)

06:57
09/24/18
09/24
06:57
09/24/18
06:57
Hot Stocks
JinkoSolar partners with Edisun Microgrids to develop Eagle PowerTrack »

JinkoSolar and Edisun…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EYEG

EyeGate

$0.36

0.0026 (0.73%)

06:56
09/24/18
09/24
06:56
09/24/18
06:56
Hot Stocks
EyeGate completes enrollment in both PRK, PE pilot studies »

EyeGate Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.